Gladell P. Paner to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Gladell P. Paner has written about Xenograft Model Antitumor Assays.
Connection Strength
0.051
-
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
Score: 0.030
-
Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells. Clin Cancer Res. 2011 May 15; 17(10):3112-22.
Score: 0.021